Enzo Biochem. Inc. Stock
Enzo Biochem. Inc. Stock
A loss of -1.040% shows a downward development for Enzo Biochem. Inc..
Pros and Cons of Enzo Biochem. Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Enzo Biochem. Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Enzo Biochem. Inc. | -1.040% | -1.036% | -17.672% | -59.874% | -22.358% | -58.836% | -69.591% |
Surgery Partners Inc | 3.510% | 2.609% | -6.349% | -25.786% | -18.056% | -45.116% | 143.953% |
Capital Senior Living Corp. | -1.960% | 2.041% | 14.504% | 354.545% | 246.821% | -21.466% | -44.994% |
Healthstream Inc. | -0.790% | - | - | - | - | - | - |
Comments
Enzo Biochem, Inc. (NYSE: ENZ) was upgraded by analysts at StockNews.com to a "sell" rating.
Show more
Ratings data for ENZ provided by MarketBeat